Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial

Amplia Therapeutics Ltd ATX.AX:

AMPLIA THERAPEUTICS REPORTS FOUR ADDITIONAL COMPLETE RESPONSES AND IMPROVED OVERALL SURVIVAL DATA IN ACCENT PANCREATIC CANCER TRIAL

AMPLIA THERAPEUTICS LTD - REPORTS MEDIAN OVERALL SURVIVAL OF 11.1 MONTHS IN ACCENT TRIAL

AMPLIA THERAPEUTICS LTD - REPORTS UPDATED OBJECTIVE RESPONSE RATE OF 35.9% IN ACCENT TRIAL

Source text: ID:nGNX5fFw9z

Further company coverage: ATX.AX

Recent news on Amplia Therapeutics

See all news